Eli Lilly and Co Newsroom

Express News | Ro Works With Lilly to Streamline Patient Access to Authentic Zepbound Single-Dose Vials by Integrating With Lilly's Pharmacy Channel

Reuters28minutes ago

Express News | Lilly's Imlunestrant, an Oral Serd, Significantly Improved Progression-Free Survival as Monotherapy and in Combination With Verzenio® (Abemaciclib) in Patients With Er+, Her2- Advanced Breast Cancer

Reuters42minutes ago

Express News | Ro: Vials to Be Available With on-Label Prescription From a Ro-Affiliated Provider via Integration With Lillydirect Self-Pay Pharmacy Channel

Reuters55minutes ago

Bank of America: Resuming coverage of Eli Lilly and Co, rating it as 'Buy'.

Bank of America resumes coverage on Eli Lilly and Co, assigning a "Buy" rating with a Target Price of $997.

Gelonghui Finance04:00 ET

BofA Securities Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Cuts Target Price to $997

Moomoo News03:32 ET · Ratings

Lilly's Imlunestrant, an Oral SERD, Significantly Improved Progression-Free Survival as Monotherapy and in Combination With Verzenio (Abemaciclib) in Patients With ER+, HER2- Advanced Breast Cancer

Eli Lilly & Co.00:00 ET

Eli Lilly and Co (LLY.US) seeks to expand the indications for its weight loss medication and will conduct trials to treat addictive behaviors.

Eli Lilly and Co will test a weight loss drug for treating addiction in 2025.

Zhitong Finance22:25 ET

BofA Restarts Coverage of 11 Large-cap Biopharmas

Seeking Alpha17:01 ET

Market Falls Wednesday, but Googles Chip Impresses | WST

Kevin Travers16:19 ET

Eli Lilly's $15 Billion Buyback Faces Stiff Resistance On The Charts

Benzinga13:59 ET

What's Going On With Eli Lilly Stock On Tuesday?

Benzinga11:52 ET

Google's Quantum Chip Might Have Contacted Parallel Universes | Live Stock

Kevin TraversDec 10 10:51 ET

Arvinas, Pfizer Present 'Encouraging' Preliminary Data for Prospective Breast Cancer Treatment

MT NewswiresDec 10 10:05 ET

Sector Update: Health Care Stocks Steady Pre-Bell Tuesday

MT NewswiresDec 10 09:07 ET

Eli Lilly and Company (LLY) Is Attracting Investor Attention: Here Is What You Should Know

Zacks Dec 10 08:10 ET

Market-Moving News for December 10th

BenzingaDec 10 07:32 ET

Express News | B of A Securities Reinstates Buy on Eli Lilly, Announces $997 Price Target

BenzingaDec 10 07:23 ET

Eli Lilly Analyst Ratings

BenzingaDec 10 07:22 ET · Ratings

As Eli Lilly Shares Gain Over 35% YTD, Drugmaker Announces $15B Share Buyback Program And Boosts Dividend By 15%

BenzingaDec 10 06:34 ET

Eli Lilly Declares Higher Dividend for Fiscal Q1

MT NewswiresDec 9 23:55 ET